683 Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Sell
40,000
-2,000
-5% -$657K 0.61% 35
2025
Q4
$14.7M Buy
42,000
+24,000
+133% +$8.11M 0.64% 37
2025
Q3
$5.82M Sell
18,000
-7,000
-28% -$2.18M 0.3% 68
2025
Q2
$9.72M Sell
25,000
-2,000
-7% -$804K 0.64% 45
2025
Q1
$11.7M Buy
+27,000
New +$10.8M 0.81% 33

Other funds holding ELV

683 Capital Management's ELV Position: Q1 2026 in Review

683 Capital Management reduced its Elevance Health (ELV) stake by 4.8% in Q1 2026, selling an estimated $657K and leaving 40,000 shares worth $11.7M. The position accounts for 0.61% of the portfolio, ranked #35.

683 Capital Management first reported a position in ELV in Q1 2025 and has held it in 5 quarters since. The position peaked at $14.7M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • 683 Capital Management held 40,000 shares of Elevance Health worth $11.7M as of Q1 2026.
  • 683 Capital Management sold 2,000 Elevance Health shares in Q1 2026, an estimated $657K.
  • Elevance Health made up 0.61% of 683 Capital Management's portfolio in Q1 2026, its #35 holding.
  • 683 Capital Management first reported a position in Elevance Health in Q1 2025 and has held it in 5 quarters since.
  • 683 Capital Management's Elevance Health position peaked at $14.7M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.